Vetter’s Newest Facility Successfully Completes FDA Inspection
News Mar 28, 2013
Vetter has announced that its new center for visual inspection and logistics passed its first GMP inspection by the U.S. Food and Drug Administration (FDA).
The inspection was conducted March 11 through 14 to ensure the facility is in compliance with good manufacturing practices.
The facility was already granted manufacturing approval and cGMP certification for Europa from the RP Tuebingen, Germany in 2012.
The 18,000-square-meter facility, known as Ravensburg Vetter West (RVW), began operations in April 2012.
The site provides high-bay warehousing for cold storage and room-temperature products, as well as visual inspection.
Featuring technology, which helps adapted to the needs of the separate supply and manufacturing processes, RVW also harnesses extensive use of renewable energy sources, including photovoltaic and geothermal.
“We’re pleased with the outcome of Ravensburg Vetter West’s first FDA GMP inspection,” said managing director Thomas Otto.
Otto continued, “We at Vetter work diligently to meet regulatory requirements. Maintaining high quality standards is a job we take seriously to be a reliable and efficient partner for our customers.”
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
Sartorius Stedim Biotech and Siemens Sign Automation AgreementNews
Siemens becomes a preferred supplier for automation solutions. Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future.READ MORE
Cocaine Use Alters Gene Expression in Brain Reward CircuitsNews
A study in Biological Psychiatry investigates transcriptome-wide alterations in response to cocaine self-administration in mice.